Sponsored by VMG Health | info@vmghealth.com | 214.369.4888

North Shore-LIJ, Cold Spring Harbor Laboratory partner for cancer care

North Shore-Long Island Jewish Health System, a 19-hosptial system based in Manhasset, N.Y., and Cold Spring Harbor (N.Y.) Laboratory announced a strategic affiliation to accelerate cancer research, diagnosis and treatment.

The affiliation will invest $120 million into advancing cancer therapeutics research, developing a new clinical cancer research unit at the North Shore-LIJ Cancer Institute's headquarters in Lake Success, N.Y., to support early-phase clinical studies of new cancer therapies, according to a news release. Some of the funds will also be used for recruiting and training more clinician-scientists in oncology.

As part of the affiliation, clinician-scientists will receive training to perform preclinical cancer research and conduct early-stage human clinical trials, according to a news release.  Positive findings from this partnership in research and therapeutics will then serve as the basis for advanced-phase clinical trials to be conducted at North Shore-LIJ facilities and collaborating outside medical centers, according to a news release.

Under the terms of the strategic affiliation, North Shore-LIJ and CSHL will continue as independent organizations governed by their respective boards. The institutions have appointed a committee with responsibility for oversight, staffing and implementation of the affiliation.

Over the past couple years, North Shore-LIJ has invested more than $175 million to open and expand cancer treatment centers throughout Long Island and New York City. North Shore-LIJ recently completed $84 million expansion of the Cancer Institute's headquarters and is also building a new $34 million, 45,500-square-foot outpatient cancer center in Bay Shore, N.Y.

CSHL has made seminal discoveries that have helped diagnose and treat cancer patients, including the discovery of the first human cancer gene in 1982, according to a news release. The CSHL Cancer Center has been a National Cancer Institute-designated Cancer Center since 1987, and is the only such center on Long Island.  CSHL, a nonprofit independent research and education institution, has an annual operating budget of $145 million and more than 35 independent laboratories and faculty focused on basic and applied cancer research.   

 

More articles on hospital transactions and valuation issues:

Details of Wellmont, Mountain States merger released

Healthcare M&A activity: 8 key points

Care New England exploring strategic partnerships

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars